{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:38:10Z","timestamp":1775821090041,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/inf.0b013e31829b8022","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T16:47:56Z","timestamp":1368636476000},"page":"1102-1109","source":"Crossref","is-referenced-by-count":66,"title":["Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9\u201316 Year Olds"],"prefix":"10.1097","volume":"32","author":[{"given":"Luis \u00c1.","family":"Villar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris M.","family":"Rivera-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Arredondo-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Boaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Starr-Spires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betzana","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda C.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo H.","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-18-20210202","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4269\/ajtmh.2010.09-0346","article-title":"The epidemiology of dengue in the americas over the last three decades: a worrisome reality.","volume":"82","author":"San Martin","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"R4-18-20210202","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1365-3156.2007.01930.x","article-title":"Short communication: impact of climate variability on the incidence of dengue in Mexico.","volume":"12","author":"Hurtado-Diaz","year":"2007","journal-title":"Trop Med Int Health"},{"key":"R7-18-20210202","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J Virol"},{"key":"R8-18-20210202","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1128\/JVI.75.16.7290-7304.2001","article-title":"Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.","volume":"75","author":"Guirakhoo","year":"2001","journal-title":"J Virol"},{"key":"R9-18-20210202","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"R10-18-20210202","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.","volume":"29","author":"Guy","year":"2011","journal-title":"Vaccine"},{"key":"R11-18-20210202","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4269\/ajtmh.2011.10-0436","article-title":"Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans.","volume":"85","author":"Qiao","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"R12-18-20210202","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/hv.2.2.2555","article-title":"Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.","volume":"2","author":"Guirakhoo","year":"2006","journal-title":"Hum Vaccin"},{"key":"R13-18-20210202","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults.","volume":"201","author":"Morrison","year":"2010","journal-title":"J Infect Dis"},{"key":"R14-18-20210202","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.vaccine.2011.03.057","article-title":"Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines.","volume":"29","author":"Capeding","year":"2011","journal-title":"Vaccine"},{"key":"R15-18-20210202","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/INF.0b013e3181fe05af","article-title":"Live-attenuated tetravalent dengue vaccine in dengue-naive children, adolescents, and adults in Mexico City: randomized controlled phase 1 trial of safety and immunogenicity.","volume":"30","author":"Poo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R16-18-20210202","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1016\/j.vaccine.2012.07.043","article-title":"Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru.","volume":"30","author":"Lanata","year":"2012","journal-title":"Vaccine"},{"key":"R17-18-20210202","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4161\/hv.21224","article-title":"Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore.","volume":"8","author":"Sin Leo","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"R18-18-20210202","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jviromet.2008.03.026","article-title":"Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines.","volume":"151","author":"Mantel","year":"2008","journal-title":"J Virol Methods"},{"key":"R19-18-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4049\/jimmunol.99.2.285","article-title":"A plaque reduction test for dengue virus neutralizing antibodies.","volume":"99","author":"Russell","year":"1967","journal-title":"J Immunol"},{"key":"R20-18-20210202","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/vim.2008.0007","article-title":"Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses.","volume":"21","author":"Roehrig","year":"2008","journal-title":"Viral Immunol"},{"key":"R21-18-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcv.2009.11.001","article-title":"Early diagnosis of dengue in travelers: comparison of a novel real-time RT-PCR, NS1 antigen detection and serology.","volume":"47","author":"Huhtamo","year":"2010","journal-title":"J Clin Virol"},{"key":"R22-18-20210202","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial.","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"R23-18-20210202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.2001.tb02696.x","article-title":"Laboratory testing for West Nile virus: panel discussion.","volume":"951","author":"Campbell","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"R24-18-20210202","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1590\/S0124-00642008000200010","article-title":"Dengue-yellow fever sera cross-reactivity; challenges for diagnosis.","volume":"10","author":"Houghton-Trivino","year":"2008","journal-title":"Rev Salud Publica (Bogota)"},{"issue":"Pt 12","key":"R25-18-20210202","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1099\/vir.0.031641-0","article-title":"Flavivirus-induced antibody cross-reactivity.","volume":"92","author":"Mansfield","year":"2011","journal-title":"J Gen Virol"},{"key":"R27-18-20210202","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai school children: a randomised, controlled phase IIb trial.","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0b013e31829b8022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T19:23:17Z","timestamp":1688239397000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201310000-00018"}},"subtitle":["A Randomized, Controlled, Phase II Trial in Latin America"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31829b8022","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}